Pioglitazone and Dermatitis - atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis - atopic is reported as a side effect among people who take Pioglitazone (pioglitazone hydrochloride), especially for people who are female, 60+ old, also take Dupixent, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Dermatitis - atopic when taking Pioglitazone. It is created by eHealthMe based on reports of 12,725 people who have side effects when taking Pioglitazone from the FDA, and is updated regularly.

What is Pioglitazone?

Pioglitazone has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 12,864 Pioglitazone users. Check the latest studies of Pioglitazone.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 1,955 drugs and 1,976 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

12,725 people reported to have side effects when taking Pioglitazone.
Among them, 19 people (0.15%) have Dermatitis - atopic.

Could Pioglitazone cause Dermatitis - atopic?

Among these 19 people:

What is the gender of people who have Dermatitis - atopic when taking Pioglitazone? *

female: 53.33 %
male: 46.67 %

What is the age of people who have Dermatitis - atopic when taking Pioglitazone? *

What are other drugs people take besides Pioglitazone? *

Dupixent: 8 people, 42.11%
Metformin Hydrochloride: 5 people, 26.32%
Omeprazole: 5 people, 26.32%
Pravastatin Sodium: 4 people, 21.05%
Bisoprolol Fumarate: 4 people, 21.05%
Lasix: 4 people, 21.05%
Losartan Potassium: 4 people, 21.05%
Aspirin: 4 people, 21.05%
Repatha: 3 people, 15.79%
Ezetimibe: 3 people, 15.79%

What are other side effects people have besides Dermatitis - atopic? *

Itching: 5 people, 26.32%
Rashes (redness): 4 people, 21.05%
Injection Site Pain: 3 people, 15.79%
Dry Skin: 3 people, 15.79%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.79%
High Blood Pressure: 3 people, 15.79%
Cough: 2 people, 10.53%
Diarrhea: 2 people, 10.53%
Skin Exfoliation (removal of the oldest dead skin cells): 2 people, 10.53%
Skin Haemorrhage (bleeding into skin): 2 people, 10.53%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 9 people, 47.37%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 2 people, 10.53%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.26%
Herpes Zoster: 1 person, 5.26%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 5.26%
Breast Cancer Metastatic: 1 person, 5.26%
Cough: 1 person, 5.26%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.26%
High Blood Cholesterol: 1 person, 5.26%
Stomatitis (inflammation of mucous membrane of mouth): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Pioglitazone and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pioglitazone:

Pioglitazone (12,864 reports)

Browse all side effects of Pioglitazone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,955 drugs)

Browse all the conditions that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,976 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pioglitazone hydrochloride (the active ingredients of Pioglitazone) and Pioglitazone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.